Search Results - "Bonnet, A.M."

Refine Results
  1. 1

    Neuropsychological changes between off and on STN or GPi stimulation in parkinson's disease by PILLON, B, ARDOUIN, C, DAMIER, P, KRACK, P, HOUETO, J. L, KLINGER, H, BONNET, A. M, POLLAK, P, BENABID, A. L, AGID, Y

    Published in Neurology (08-08-2000)
    “…In a previous study on a consecutive series of 62 patients with PD, the authors showed that bilateral subthalamic or pallidal continuous high-frequency deep…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Behavioural disorders, Parkinson's disease and subthalamic stimulation by Houeto, J L, Mesnage, V, Mallet, L, Pillon, B, Gargiulo, M, du Moncel, S Tezenas, Bonnet, A M, Pidoux, B, Dormont, D, Cornu, P, Agid, Y

    “…Objective: to analyse 24 parkinsonian patients successfully treated by bilateral STN stimulation for the presence of behavioural disorders. Method: patients…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Improvement of sleep architecture in PD with subthalamic nucleus stimulation by ARNULF, I, BEJJANI, B. P, GARMA, L, BONNET, A. M, HOUETO, J. L, DAMIER, P, DERENNE, J. P, AGID, Y

    Published in Neurology (12-12-2000)
    “…High-frequency stimulation of the subthalamic nucleus (STN) was used to investigate the relationship of sleep disorders with motor handicap in PD. In 10…”
    Get full text
    Journal Article
  7. 7

    Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease by Rascol, O., Arnulf, I., Peyro-Saint Paul, H., Brefel-Courbon, C., Vidailhet, M., Thalamas, C., Bonnet, A.M., Descombes, S., Bejjani, B., Fabre, N., Montastruc, J.L., Agid, Y.

    Published in Movement disorders (01-07-2001)
    “…Dyskinesia is a frequent and disabling side effect in patients with Parkinson's disease treated with chronic dopatherapy. Preclinical data in the…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Failure of long-term pallidal stimulation corrected by subthalamic stimulation in PD by HOUETO, J. L, BEJJANI, P. B, DAMIER, P, STAEDLER, C, BONNET, A. M, PIDOUX, B, DORMONT, D, CORNU, P, AGID, Y

    Published in Neurology (12-09-2000)
    “…Bilateral high-frequency continuous stimulation of the internal globus pallidus or subthalamic nucleus constitutes a new therapeutic approach for the treatment…”
    Get full text
    Journal Article
  10. 10

    Characterization of GFP-MAL expression and incorporation in rafts by Caduff, J., Sansano, S., Bonnet, A., Suter, U., Schaeren-Wiemers, N.

    Published in Microscopy research and technique (15-03-2001)
    “…During myelin formation, membrane‐associated proteins have to be sorted and transported in specified membrane regions such as compact and non‐compact myelin…”
    Get full text
    Journal Article
  11. 11

    Dual-release formulation, a novel principle in L-dopa treatment of Parkinson's disease by DESCOMBES, S, BONNET, A. M, GASSER, U. E, THALAMAS, C, DINGEMANSE, J, ARNULF, I, BAREILLE, M. P, AGID, Y, RASCOL, O

    Published in Neurology (08-05-2001)
    “…A single morning dose of dual-release formulation was compared with a slow-release formulation of L-dopa plus benserazide in a randomized, double-blind,…”
    Get full text
    Journal Article
  12. 12

    Cytogenetic comparison between Vietnamese sika deer and cattle: R-banded karyotypes and FISH mapping by Bonnet, A, Thévenon, S, Claro, F, Gautier, M, Hayes, H

    Published in Chromosome research (01-01-2001)
    “…R-banded chromosomes of Vietnamese sika (VS) deer (Cervus nippon pseudaxis, 2N = 66), a threatened subspecies of sika deer endemic to Vietnam, are presented…”
    Get full text
    Journal Article
  13. 13

    Pathophysiology of Parkinson's disease by Bonnet, A.M., Houeto, J.L.

    Published in Biomedicine & pharmacotherapy (01-04-1999)
    “…Parkinson's disease is a progressive disease with selective dopaminergic neuronal loss. The pathophysiology is at present better understood with plurifactorial…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Blockade of cholecystokinin-A receptors has no effect on dyskinesias in Parkinson's disease by ARNULF, I, VIDAILHET, M, BONNET, A-M, DESCOMBES, S, JAILLON, C, AGID, Y, BREFEL, C, RASCOL, O, XIE, J, POLLAK, P, CATTELIN, F

    “…[...]the absence of an effect of SR on any type of dyskinesia suggests that cholecystokinin may not modulate dopamine release at the level of striatal…”
    Get full text
    Journal Article
  16. 16
  17. 17

    In-Vivo SPECT Imaging of D2 Receptor with, Iodine-Iodolisuride: Results in Supranuclear Palsy by Chabriat, H, Levasseur, M, Vidailhet, M, Loc'h, C, Maziere, B, Bourguignon, M.H, Bonnet, A.M, Zilbovicius, M, Raynaud, C, Agid, Y, Syrota, A, Samson, Y

    Published in The Journal of nuclear medicine (1978) (01-08-1992)
    “…We assessed the potential use of [123I]iodolisuride (ILIS), a new iodine ergolene derivative, to study human striatal D2 dopamine receptors with SPECT. In…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20